As Financial Turmoil Engulfs West, Germany’s Bayer Looks East To Form R&D Center In Rising China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - German pharmaceutical powerhouse Bayer Schering is engineering an alliance with Chinese scientists to create a global research and development center in Beijing, according to senior Bayer executives
You may also be interested in...
Bayer’s Alok Kanti On Price Cuts And Lower-tier Markets In China: An Interview With PharmAsia News
In his first public interview since assuming leadership for Bayer Healthcare China in July, Alok Kanti discusses Bayer’s strategy in China.
Bayer’s Alok Kanti On Price Cuts And Lower-tier Markets In China: An Interview With PharmAsia News
In his first public interview since assuming leadership for Bayer Healthcare China in July, Alok Kanti discusses Bayer’s strategy in China.
China Will Seize Ranking As Globe's Top Innovative Center From U.S. By 2020: AstraZeneca Survey
BEIJING - A survey commissioned by British-headquartered AstraZeneca that polled public perceptions across three continents - Europe, North America and Asia -predicts that China will dethrone the United States to become the globe's most innovative center by 2020